Literature DB >> 33321047

Secretory Cells Dominate Airway CFTR Expression and Function in Human Airway Superficial Epithelia.

Kenichi Okuda1, Hong Dang1, Yoshihiko Kobayashi2, Gianni Carraro3, Satoko Nakano1, Gang Chen1, Takafumi Kato1, Takanori Asakura1, Rodney C Gilmore1, Lisa C Morton1, Rhianna E Lee1, Teresa Mascenik1, Wei-Ning Yin1, Selene Margarita Barbosa Cardenas1, Yvonne K O'Neal1, Caroline E Minnick1, Michael Chua1, Nancy L Quinney1, Martina Gentzsch1, Carlton W Anderson4, Andrew Ghio5, Hirotoshi Matsui6, Takahide Nagase7, Lawrence E Ostrowski1, Barbara R Grubb1, John C Olsen1, Scott H Randell1, Barry R Stripp3, Purushothama Rao Tata2, Wanda K O'Neal1, Richard C Boucher1.   

Abstract

Rationale: Identification of the specific cell types expressing CFTR (cystic fibrosis [CF] transmembrane conductance regulator) is required for precision medicine therapies for CF. However, a full characterization of CFTR expression in normal human airway epithelia is missing.
Objectives: To identify the cell types that contribute to CFTR expression and function within the proximal-distal axis of the normal human lung.
Methods: Single-cell RNA (scRNA) sequencing (scRNA-seq) was performed on freshly isolated human large and small airway epithelial cells. scRNA in situ hybridization (ISH) and single-cell qRT-PCR were performed for validation. In vitro culture systems correlated CFTR function with cell types. Lentiviruses were used for cell type-specific transduction of wild-type CFTR in CF cells. Measurements and Main
Results: scRNA-seq identified secretory cells as dominating CFTR expression in normal human large and, particularly, small airway superficial epithelia, followed by basal cells. Ionocytes expressed the highest CFTR levels but were rare, whereas the expression in ciliated cells was infrequent and low. scRNA ISH and single-cell qRT-PCR confirmed the scRNA-seq findings. CF lungs exhibited distributions of CFTR and ionocytes similar to those of normal control subjects. CFTR mediated Cl- secretion in cultures tracked secretory cell, but not ionocyte, densities. Furthermore, the nucleotide-purinergic regulatory system that controls CFTR-mediated hydration was associated with secretory cells and not with ionocytes. Lentiviral transduction of wild-type CFTR produced CFTR-mediated Cl- secretion in CF airway secretory cells but not in ciliated cells. Conclusions: Secretory cells dominate CFTR expression and function in human airway superficial epithelia. CFTR therapies may need to restore CFTR function to multiple cell types, with a focus on secretory cells.

Entities:  

Keywords:  CFTR; airway secretory cells; ionocytes; single-cell RNA sequencing

Year:  2021        PMID: 33321047     DOI: 10.1164/rccm.202008-3198OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  28 in total

1.  Human distal lung maps and lineage hierarchies reveal a bipotent progenitor.

Authors:  Preetish Kadur Lakshminarasimha Murthy; Vishwaraj Sontake; Aleksandra Tata; Yoshihiko Kobayashi; Lauren Macadlo; Kenichi Okuda; Ansley S Conchola; Satoko Nakano; Simon Gregory; Lisa A Miller; Jason R Spence; John F Engelhardt; Richard C Boucher; Jason R Rock; Scott H Randell; Purushothama Rao Tata
Journal:  Nature       Date:  2022-03-30       Impact factor: 69.504

2.  Krüppel-Like Factor 5 Regulates CFTR Expression Through Repression by Maintaining Chromatin Architecture Coupled with Direct Enhancer Activation.

Authors:  Alekh Paranjapye; Monali NandyMazumdar; Ann Harris
Journal:  J Mol Biol       Date:  2022-03-24       Impact factor: 6.151

Review 3.  Established and novel human translational models to advance cystic fibrosis research, drug discovery, and optimize CFTR-targeting therapeutics.

Authors:  Deborah M Cholon; Martina Gentzsch
Journal:  Curr Opin Pharmacol       Date:  2022-04-21       Impact factor: 4.768

4.  Transcriptional analysis of cystic fibrosis airways at single-cell resolution reveals altered epithelial cell states and composition.

Authors:  Gianni Carraro; Justin Langerman; Shan Sabri; Zareeb Lorenzana; Arunima Purkayastha; Guangzhu Zhang; Bindu Konda; Cody J Aros; Ben A Calvert; Aleks Szymaniak; Emily Wilson; Michael Mulligan; Priyanka Bhatt; Junjie Lu; Preethi Vijayaraj; Changfu Yao; David W Shia; Andrew J Lund; Edo Israely; Tammy M Rickabaugh; Jason Ernst; Martin Mense; Scott H Randell; Eszter K Vladar; Amy L Ryan; Kathrin Plath; John E Mahoney; Barry R Stripp; Brigitte N Gomperts
Journal:  Nat Med       Date:  2021-05-06       Impact factor: 53.440

5.  Epigenome editing of the CFTR-locus for treatment of cystic fibrosis.

Authors:  Ami M Kabadi; Leah Machlin; Nikita Dalal; Rhianna E Lee; Ian McDowell; Nirav N Shah; Lauren Drowley; Scott H Randell; Timothy E Reddy
Journal:  J Cyst Fibros       Date:  2021-05-25       Impact factor: 5.482

6.  Update in Pediatrics 2020.

Authors:  Erick Forno; Steven H Abman; Jagdev Singh; Mary E Robbins; Hiran Selvadurai; Paul T Schumacker; Paul D Robinson
Journal:  Am J Respir Crit Care Med       Date:  2021-08-01       Impact factor: 30.528

Review 7.  Human Molecular Genetics and the long road to treating cystic fibrosis.

Authors:  Ann Harris
Journal:  Hum Mol Genet       Date:  2021-10-01       Impact factor: 5.121

8.  Increased CFTR expression and function from an optimized lentiviral vector for cystic fibrosis gene therapy.

Authors:  Laura I Marquez Loza; Ashley L Cooney; Qian Dong; Christoph O Randak; Stefano Rivella; Patrick L Sinn; Paul B McCray
Journal:  Mol Ther Methods Clin Dev       Date:  2021-02-27       Impact factor: 5.849

Review 9.  Airway Surface Liquid pH Regulation in Airway Epithelium Current Understandings and Gaps in Knowledge.

Authors:  Miroslaw Zajac; Elise Dreano; Aurelie Edwards; Gabrielle Planelles; Isabelle Sermet-Gaudelus
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923

Review 10.  Revisiting CFTR Interactions: Old Partners and New Players.

Authors:  Carlos M Farinha; Martina Gentzsch
Journal:  Int J Mol Sci       Date:  2021-12-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.